1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with salmeterol xinafoate in 8 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (salmeterol xinafoate) | Trials (salmeterol xinafoate) | Recent Studies (post-2010) (salmeterol xinafoate) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 1,872 | 684 | 398 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ind, PW; Johnston, SR; Seale, J; Spring, J | 1 |
| Johnson, M; Vardey, CJ; Whelan, CJ | 1 |
| Anderson, R; Cole, PJ; Feldman, C; Ramafi, G; Theron, AJ; Wilson, R | 1 |
| Knol, EF; Mul, FP; Roos, D; Tool, AT; Verhoeven, AJ | 1 |
| Hellewell, PG; Teixeira, MM | 1 |
| al-Hage, M; Ezeamuzie, CI; Nwankwoala, RN | 1 |
| Aslander, MM; Brinkman, L; Grutters, JC; Koenderman, L; Lammers, JW; van den Bosch, JM | 1 |
| Baluk, P; Gómez, AD; Hashizume, H; Kwan, ML; McDonald, DM | 1 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and salmeterol xinafoate
| Article | Year |
|---|---|
Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bronchoconstriction; Double-Blind Method; Female; Humans; Inflammation; Leukocyte Count; Lymphocytes; Lymphopenia; Male; Neutrophils; Platelet Activating Factor; Salmeterol Xinafoate | 1992 |
Asthma therapy modulates priming-associated blood eosinophil responsiveness in allergic asthmatics.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Allergens; Asthma; Beclomethasone; Blood Proteins; Bronchial Provocation Tests; Double-Blind Method; Drug Therapy, Combination; Eosinophil Granule Proteins; Eosinophils; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Platelet Activating Factor; Reactive Oxygen Species; Respiratory Burst; Ribonucleases; Salmeterol Xinafoate; Treatment Outcome; Zymosan | 1999 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and salmeterol xinafoate
| Article | Year |
|---|---|
Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Proteins; Bronchoalveolar Lavage Fluid; Ethanolamines; Formoterol Fumarate; Granulocytes; Guinea Pigs; Histamine; Humans; In Vitro Techniques; Infant, Newborn; Lung; Male; Neutrophils; Platelet Activating Factor; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Skin | 1993 |
Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Adult; Albuterol; Anti-Inflammatory Agents; Asthma; Calcium; Cell Membrane; Ethanolamines; Fenoterol; Formoterol Fumarate; Humans; In Vitro Techniques; NADH, NADPH Oxidoreductases; Neutrophils; Oxygen Consumption; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Protein Kinase C; Salmeterol Xinafoate; Superoxides | 1996 |
The effect of salmeterol and nimesulide on chemotaxis and synthesis of PAF and LTC4 by human eosinophils.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Chemotaxis; Complement C5a; Cyclic AMP; Eosinophils; Granulocyte-Macrophage Colony-Stimulating Factor; Guinea Pigs; Humans; Leukotriene C4; Platelet Activating Factor; Salmeterol Xinafoate; Sulfonamides | 1996 |
Evidence that the eosinophil is a cellular target for the inhibitory action of salmeterol on eosinophil recruitment in vivo.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Cell Aggregation; Depression, Chemical; Eosinophils; Guinea Pigs; Humans; Platelet Activating Factor; Salmeterol Xinafoate; Skin; Zymosan | 1997 |
The effect of salmeterol on human eosinophils is both stimulus- and response-dependent.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; beta-N-Acetylhexosaminidases; Cell Adhesion; Eosinophil Peroxidase; Eosinophils; Fibronectins; Humans; Interleukin-5; Leukotriene B4; Peroxidases; Platelet Activating Factor; Propanolamines; Salmeterol Xinafoate; Superoxides; Tetradecanoylphorbol Acetate | 1997 |
Airway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.
Topics: Albuterol; Animals; Bronchodilator Agents; Capillary Permeability; Chronic Disease; Dose-Response Relationship, Drug; Drug Hypersensitivity; Evans Blue; Extravasation of Diagnostic and Therapeutic Materials; Indoles; Male; Mycoplasma Infections; Organ Size; Organometallic Compounds; Platelet Activating Factor; Rats; Rats, Inbred F344; Rats, Wistar; Salmeterol Xinafoate; Serotonin; Species Specificity; Specific Pathogen-Free Organisms; Substance P; Trachea | 2001 |